1-3 of 3
Ehsan Tabari
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of High-Risk Population in First-Line Follicular Lymphoma at Screening with a Next Generation Sequencing (NGS) Assay Using Plasma Circulating Tumor DNA (ctDNA): Initial Data from Gallium

Alessia Bottos, Corinna Woestmann, Christopher R. Bolen, Maria Shin, Patrick Bogard, Ehsan Tabari, Andrew S. Davies, Andrea Knapp, Tina Nielsen, Oliver Weigert, Elicia Penuel
Journal: Blood
Blood (2023) 142 (Supplement 1): 1629.
https://doi.org/10.1182/blood-2023-181723
Published: 2023
Journal Articles

Detection of Early Molecular Response (EMR) and Minimal Residual Disease (MRD) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Using a Validated Next Generation Sequencing (NGS) Assay for the Detection of Tumor Variants in Circulating Tumor (ct)DNA

Renee P Stokowski, Ehsan Tabari, Patrick Bogard, Coleen Hacker, Olga K Kameneva, Tieming Ji, Li Teng, Vladislava Melnikova, Ron McCord, Elizabeth A Punnoose, Robert Loberg, Junaid Shabbeer
Journal: Blood
Blood (2022) 140 (Supplement 1): 9257–9258.
https://doi.org/10.1182/blood-2022-162814
Published: 2022
Journal Articles

Molecular Characteristics and Disease Burden Metrics Determined By Next-Generation Sequencing on Circulating Tumor DNA Correlate with Progression Free Survival in Previously Untreated Diffuse Large B-Cell Lymphoma

Ehsan Tabari, PhD, Alexander F Lovejoy, PhD, Hai Lin, PhD, Christopher R Bolen, PhD, Seng Lor Saelee, BA, Joshua P Lefkowitz, David M. Kurtz, MD PhD, Patrik Vitazka, MD PhD, Jeffrey M. Venstrom, MD PhD, Tina G Nielsen, MD PhD, Joana M Parreira, MD, Daniel M Klass, PhD, Khai T Luong, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 490.
https://doi.org/10.1182/blood-2019-123633
Published: 2019